Home
Approach
Our Values
Research
How We Work
Pedagogy
Research
Health Equity
Health Capability
Health Efficiency
Resource Allocation
Health Financing
Health Governance
Theories
Collaboration
People
Collaborators
Co-Author Matrix
Research Network
Funding
Publications
News

Health Equity & Policy Lab

Home
Approach
Our Values
Research
How We Work
Pedagogy
Research
Health Equity
Health Capability
Health Efficiency
Resource Allocation
Health Financing
Health Governance
Theories
Collaboration
People
Collaborators
Co-Author Matrix
Research Network
Funding
Publications
News
  • Health Efficiency
  • Micro-Costing
  • Micro-Costing Checklist
  • Micro-Costing Critical Appraisal
  • Application: Costs of Addiction Treatment
  • How can microcosting be used to evaluate smoking cessation and relapse prevention interventions?
  • How can we use microcosting in policy making for HIV Interventions?
  • What are the costs of treatment for heroin addiction in 33 countries worldwide?
  • Is it costly to target pregnant women with substance use and HIV prevention programs?
  • Economic Evaluation
  • Economic Evaluation of Substance Abuse and HIV/AIDS Prevention for Women
  • Smoking Cessation and Relapse Prevention
  • Economic Evaluations of Smoking Cessation and Relapse Prevention
  • Motivational Interviewing for Smoking Cessation
  • Micro-Costing Methodology
  • Cost Effective of Pharmaco and Behavioral therapies for Smoking Cessation
  • Drug Abuse Treatment and Prevention of Other Risky Behavior
  • Substance Abuse Interventions
  • Are peer-delivered interventions for cocaine and alcohol abuse among women cost-effective?
  • Most Cost-Effective Intervention to Prevent HIV/AIDS and STDs among Women
  • Cost Effective Treatments for Heroin Dependence
  • Drug Abuse and HIV Prevention Programs
  • Substance Use In Pregnant Women
  • How does pregnancy intervention impact substance use abstinence
  • Postpartum Contraception
  • Behavioral Intervention for Substance Use Treatment

ECONOMIC EVALUATION OF ADDICTION TREATMENT AND RISKY BEHAVIOR PREVENTION

HIV_Aids.jpg

ECONOMIC EVALUATION OF SUBSTANCE ABUSE TREATMENT AND HIV/AIDS PREVENTION FOR WOMEN

Motivational_Interviewing_For_Smoking_Cessation.jpg

SMOKING CESSATION AND RELAPSE PREVENTION

Substance_Abuse_And_Mental_Disorder.jpg

ALCOHOL, COCAINE, MARIJUANA, OPIOID, HERION, HALLUCINOGENS, AMPHETAMINE ABUSE TREATMENT AND PREVENTION OF OTHER RISKY BEHAVIORS

BACK TO HEALTH EFFICIENCY

Health Equity & Policy Lab at the University of Pennsylvania

Back to Top
Contact
 
twitter.png
email-white.png